The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker: Study design and protocol

The epilepsy bioinformatics study for anti-epileptogenic therapy (EpiBioS4Rx) clinical biomarker: Study design and protocol

The Epilepsy Bioinformatics Study for Anti-epileptogenic Therapy (EpiBioS4Rx) is a longitudinal prospective observational study funded by the National Institute of Health (NIH) to discover and validate observational biomarkers of epileptogenesis after traumatic brain injury (TBI). A multidisciplinar...

Full description

Bibliographic Details
Main Authors: Paul M. Vespa, Vikesh Shrestha, Nicholas Abend, Denes Agoston, Alicia Au, Michael J. Bell, Thomas P. Bleck, Manuel Buitrago Blanco, Jan Claassen, Ramon Diaz-Arrastia, Dominique Duncan, Ben Ellingson, Brandon Foreman, Emily J. Gilmore, Lawrence Hirsch, Martin Hunn, Alaa Kamnaksh, David McArthur, Andrew Morokoff, Terrence O'Brien, Kristine O'Phelan, Courtney L. Robertson, Eric Rosenthal, Richard Staba, Arthur Toga, Frederick A. Willyerd, Lara Zimmermann, Elisa Yam, Susana Martinez, Courtney Real, Jerome Engel, Jr
Format: Article
Language:English
Published: Elsevier 2019-03-01
Series:Neurobiology of Disease
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996118303115

Internet

http://www.sciencedirect.com/science/article/pii/S0969996118303115

Similar Items